Quantcast

MEDSEEK Unveils New Influence Platform Capabilities at HIMSS 2013

March 4, 2013

Helping Hospitals Respond to Rising Consumer Expectations and Shift to Value-Based Payment

(PRWEB) March 04, 2013

MEDSEEK announced today that it is expanding the capabilities of its MEDSEEK Influence platform to help healthcare organizations move beyond patient engagement to influence–giving organizations the power to strategically guide patient decisions and behaviors before and after a clinical encounter. The industry leader in healthcare consumer-facing technology will continue its history of innovation by showcasing many of these new capabilities at HIMSS 2013 in New Orleans.

Most hospitals and health systems are concentrated on patient engagement because Meaningful Use requirements seem to align well with their goals to deliver patient-centered care. However, as patients transition from recipients of care to active participants and as payers move towards value-based payment, hospitals and health systems will find Meaningful Use focused solutions do not give them the virtual influence they need to successfully take on an imminently broader set of responsibilities. Leveraging core concepts of persuasion psychology to expand the breadth and capabilities of the solutions it offers, MEDSEEK is looking ahead to support the needed shift to influence patients in making better health choices, outside the four walls of the healthcare facility.

To best influence patient decisions, behaviors and results, moving beyond the one size fits all approach to meet consumers where they are is of essence. With integration between its MEDSEEK Predict, predictive analytics and healthcare CRM solution, MEDSEEK Convert enterprise content management system and MEDSEEK Empower enterprise patient portal becoming a reality, the MEDSEEK Influence platform will provide hospitals the comprehensive view they need of each individual, as well as advanced personalization capabilities on par with e-commerce solutions.

“By cultivating a deeply personalized and prescriptive experience for patients, healthcare organizations can more effectively influence the day-to-day decisions that directly affect their bottom-line,” states Peter Kuhn MEDSEEK CEO. “We are driven every day to deliver and help healthcare organizations leverage consumer-facing technologies to achieve their strategic goals.”

As payment models move towards value-based care, technology that provides patients with tailored knowledge, dynamic tools, and appropriate reminders to manage their health is of essence to help prevent readmissions and cultivate successful ACO-like arrangements. The MEDSEEK Influence platform is the only solution on the market that can help hospitals better predict the needs of individuals, target those individuals with relevant content, convert more of the high value prospects into loyal patients, and empower those patients to make better, more informed health decisions.

To further discover how the MEDSEEK Influence platform is changing to help healthcare organizations achieve their revenue, cost and quality goals, visit MEDSEEK at the HIMSS Conference, booth 3858, and view our new interactive demonstration outlining the virtual experience of fictitious e-patient, Joyce Campbell, or contact us at marketing@medseek.com.

About MEDSEEK

Since 1996, MEDSEEK has focused exclusively on building software to help hospitals and health systems virtually influence prospects and patients before and after a physical encounter. Today, the MEDSEEK Influence platform integrates web, mobile, social, predictive analytics and relationship management solutions to help organizations drive profitable volume, improve individual and population health, increase patient satisfaction and create lasting health-related loyalty. Birmingham, AL-based MEDSEEK is proud to serve over 200 customers representing over 1,000 hospitals including many of the top hospital systems in the United States and Canada.

For the original version on PRWeb visit: http://www.prweb.com/releases/prweb2013/3/prweb10490282.htm


Source: prweb



comments powered by Disqus